214 related articles for article (PubMed ID: 22022391)
21. Intracellular expression of IRF9 Stat fusion protein overcomes the defective Jak-Stat signaling and inhibits HCV RNA replication.
Poat B; Hazari S; Chandra PK; Gunduz F; Alvarez X; Balart LA; Garry RF; Dash S
Virol J; 2010 Oct; 7():265. PubMed ID: 20939906
[TBL] [Abstract][Full Text] [Related]
22. Antiviral effect and virus-host interactions in response to alpha interferon, gamma interferon, poly(i)-poly(c), tumor necrosis factor alpha, and ribavirin in hepatitis C virus subgenomic replicons.
Lanford RE; Guerra B; Lee H; Averett DR; Pfeiffer B; Chavez D; Notvall L; Bigger C
J Virol; 2003 Jan; 77(2):1092-104. PubMed ID: 12502825
[TBL] [Abstract][Full Text] [Related]
23. Global changes in STAT target selection and transcription regulation upon interferon treatments.
Hartman SE; Bertone P; Nath AK; Royce TE; Gerstein M; Weissman S; Snyder M
Genes Dev; 2005 Dec; 19(24):2953-68. PubMed ID: 16319195
[TBL] [Abstract][Full Text] [Related]
24. Conventional protein kinase C inhibition prevents alpha interferon-mediated hepatitis C virus replicon clearance by impairing STAT activation.
Fimia GM; Evangelisti C; Alonzi T; Romani M; Fratini F; Paonessa G; Ippolito G; Tripodi M; Piacentini M
J Virol; 2004 Dec; 78(23):12809-16. PubMed ID: 15542633
[TBL] [Abstract][Full Text] [Related]
25. Understanding the molecular mechanism(s) of hepatitis C virus (HCV) induced interferon resistance.
Qashqari H; Al-Mars A; Chaudhary A; Abuzenadah A; Damanhouri G; Alqahtani M; Mahmoud M; El Sayed Zaki M; Fatima K; Qadri I
Infect Genet Evol; 2013 Oct; 19():113-9. PubMed ID: 23831932
[TBL] [Abstract][Full Text] [Related]
26. Gene expression associated with interferon alfa antiviral activity in an HCV replicon cell line.
Zhu H; Zhao H; Collins CD; Eckenrode SE; Run Q; McIndoe RA; Crawford JM; Nelson DR; She JX; Liu C
Hepatology; 2003 May; 37(5):1180-8. PubMed ID: 12717400
[TBL] [Abstract][Full Text] [Related]
27. HCV and flaviviruses hijack cellular mechanisms for nuclear STAT2 degradation: Up-regulation of PDLIM2 suppresses the innate immune response.
Joyce MA; Berry-Wynne KM; Dos Santos T; Addison WR; McFarlane N; Hobman T; Tyrrell DL
PLoS Pathog; 2019 Aug; 15(8):e1007949. PubMed ID: 31374104
[TBL] [Abstract][Full Text] [Related]
28. [Study of the effect of hepatitis C virus core protein on interferon-induced antiviral genes expression and its mechanisms].
Chang YZ; Lei YC; Hao YH; Chen SS; Wu W; Yang DL; Lu MJ
Sheng Wu Gong Cheng Xue Bao; 2007 Nov; 23(6):1000-4. PubMed ID: 18257226
[TBL] [Abstract][Full Text] [Related]
29. Hepatitis C virus core protein down-regulates transcription of interferon-induced antiviral genes.
de Lucas S; Bartolome J; Carreno V
J Infect Dis; 2005 Jan; 191(1):93-9. PubMed ID: 15593009
[TBL] [Abstract][Full Text] [Related]
30. Disruption of type I interferon signaling by the nonstructural protein of severe fever with thrombocytopenia syndrome virus via the hijacking of STAT2 and STAT1 into inclusion bodies.
Ning YJ; Feng K; Min YQ; Cao WC; Wang M; Deng F; Hu Z; Wang H
J Virol; 2015 Apr; 89(8):4227-36. PubMed ID: 25631085
[TBL] [Abstract][Full Text] [Related]
31. [Effect of HCV NS5A on STAT1 phosphorylation and nuclear translocation induced by IFN alpha-2b].
Cao J; Zhou Y; Gong GZ
Zhonghua Gan Zang Bing Za Zhi; 2006 Dec; 14(12):894-7. PubMed ID: 17196131
[TBL] [Abstract][Full Text] [Related]
32. The Study of Immune Response in PBMC of CHB Patients treated with IFN-α and 3-TC in vitro.
Zhang H; Guan ZS; Guan SH; Yang K; Pan Y; Wu YY; Wang AH; Sun BB; Hou J; Mu XX; Gao YF; Cheng WS
Clin Lab; 2016 Dec; 62(12):2313-2318. PubMed ID: 28164560
[TBL] [Abstract][Full Text] [Related]
33. Interferon-alpha inhibits hepatitis C virus subgenomic RNA replication by an MxA-independent pathway.
Frese M; Pietschmann T; Moradpour D; Haller O; Bartenschlager R
J Gen Virol; 2001 Apr; 82(Pt 4):723-733. PubMed ID: 11257176
[TBL] [Abstract][Full Text] [Related]
34. Cytopathic and noncytopathic interferon responses in cells expressing hepatitis C virus subgenomic replicons.
Guo JT; Zhu Q; Seeger C
J Virol; 2003 Oct; 77(20):10769-79. PubMed ID: 14512527
[TBL] [Abstract][Full Text] [Related]
35. Antiviral action of interferon-alpha against hepatitis C virus replicon and its modulation by interferon-gamma and interleukin-8.
Jia Y; Wei L; Jiang D; Wang J; Cong X; Fei R
J Gastroenterol Hepatol; 2007 Aug; 22(8):1278-85. PubMed ID: 17565587
[TBL] [Abstract][Full Text] [Related]
36. High-throughput profiling of alpha interferon- and interleukin-28B-regulated microRNAs and identification of let-7s with anti-hepatitis C virus activity by targeting IGF2BP1.
Cheng M; Si Y; Niu Y; Liu X; Li X; Zhao J; Jin Q; Yang W
J Virol; 2013 Sep; 87(17):9707-18. PubMed ID: 23824794
[TBL] [Abstract][Full Text] [Related]
37. A functional genomic screen reveals novel host genes that mediate interferon-alpha's effects against hepatitis C virus.
Zhao H; Lin W; Kumthip K; Cheng D; Fusco DN; Hofmann O; Jilg N; Tai AW; Goto K; Zhang L; Hide W; Jang JY; Peng LF; Chung RT
J Hepatol; 2012 Feb; 56(2):326-33. PubMed ID: 21888876
[TBL] [Abstract][Full Text] [Related]
38. Effect of alpha interferon on the hepatitis C virus replicon.
Guo JT; Bichko VV; Seeger C
J Virol; 2001 Sep; 75(18):8516-23. PubMed ID: 11507197
[TBL] [Abstract][Full Text] [Related]
39. Hepatitis C virus NS5A disrupts STAT1 phosphorylation and suppresses type I interferon signaling.
Kumthip K; Chusri P; Jilg N; Zhao L; Fusco DN; Zhao H; Goto K; Cheng D; Schaefer EA; Zhang L; Pantip C; Thongsawat S; O'Brien A; Peng LF; Maneekarn N; Chung RT; Lin W
J Virol; 2012 Aug; 86(16):8581-91. PubMed ID: 22674974
[TBL] [Abstract][Full Text] [Related]
40. Differential regulation of Tetraodon nigroviridis Mx gene promoter activity by constitutively-active forms of STAT1, STAT2, and IRF9.
Cheng CH; Chou CM; Chu CY; Chen GD; Lien HW; Hwang PP; Chang MS; Huang CJ
Fish Shellfish Immunol; 2014 May; 38(1):230-43. PubMed ID: 24680831
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
